Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cipta Selera Murni Tbk. (CSMI) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Cipta Selera Murni Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Cipta Selera Murni Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Cipta Selera Murni Tbk. trades at Rp124 (market cap 97.11B, 104.95M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 811.5K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 6.7× Cipta Selera Murni Tbk.'s market cap, and Cipta Selera Murni Tbk. is more actively traded (104.95M versus 811.5K). Which is the better fit depends on your goals.

CSMILABS
Market Cap
97.11B651.75B
Volume
104.95M811.5K
Lot
1.05M8.12K
Turnover
13.79B134.34M
Average Price
131.4165.55
Value
13.79B134.34M
Indicative Equilibrium Price
122165
Indicative Equilibrium Volume
2.22K300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CSMI
View details
LABS
View details

About Cipta Selera Murni Tbk.

PT Cipta Selera Murni Tbk (Company) was established based on Notarial Deed No. 167 dated July 25,1983 of Winanto Wiryomartani, S.H., in Jakarta.

Read more on CSMI

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS